Literature DB >> 16465592

Neuronal expression of the Ccm2 gene in a new mouse model of cerebral cavernous malformations.

Nicholas W Plummer1, Teresa L Squire, Sudha Srinivasan, Elizabeth Huang, Jon S Zawistowski, Hiroaki Matsunami, Laura P Hale, Douglas A Marchuk.   

Abstract

Cerebral cavernous malformations are vascular defects of the central nervous system consisting of clusters of dilated vessels that are subject to frequent hemorrhaging. The genes mutated in three forms of autosomal dominant cerebral cavernous malformations have been cloned, but it remains unclear which cell type is ultimately responsible for the lesion. In this article we describe mice with a gene trap insertion in the Ccm2 gene. Consistent with the human phenotype, heterozygous animals develop cerebral vascular malformations, although penetrance is low. Beta-galactosidase activity in heterozygous brain and in situ hybridization in wild-type brain revealed Ccm2 expression in neurons and choroid plexus but not in vascular endothelium of small vessels in the brain. The expression pattern of Ccm2 is similar to that of the Ccm1 gene and its interacting protein ICAP1 (Itgb1bp1). These data suggest that cerebral cavernous malformations arise as a result of defects in the neural parenchyma surrounding the vascular endothelial cells in the brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16465592     DOI: 10.1007/s00335-005-0098-8

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


  32 in total

1.  Interaction between krit1 and icap1alpha infers perturbation of integrin beta1-mediated angiogenesis in the pathogenesis of cerebral cavernous malformation.

Authors:  J Zhang; R E Clatterbuck; D Rigamonti; D D Chang; H C Dietz
Journal:  Hum Mol Genet       Date:  2001-12-01       Impact factor: 6.150

2.  Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.

Authors:  J H Wong; I A Awad; J H Kim
Journal:  Neurosurgery       Date:  2000-06       Impact factor: 4.654

3.  Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock.

Authors:  Mark T Uhlik; Amy N Abell; Nancy L Johnson; Weiyong Sun; Bruce D Cuevas; Katherine E Lobel-Rice; Eric A Horne; Mark L Dell'Acqua; Gary L Johnson
Journal:  Nat Cell Biol       Date:  2003-11-23       Impact factor: 28.824

Review 4.  Wiring the vascular circuitry: from growth factors to guidance cues.

Authors:  Lisa D Urness; Dean Y Li
Journal:  Curr Top Dev Biol       Date:  2004       Impact factor: 4.897

Review 5.  Applications of magnetic resonance microscopy.

Authors:  Robert R Maronpot; Robert C Sills; G Allan Johnson
Journal:  Toxicol Pathol       Date:  2004 Jul-Aug       Impact factor: 1.902

6.  Mutations in the gene encoding KRIT1, a Krev-1/rap1a binding protein, cause cerebral cavernous malformations (CCM1).

Authors:  T Sahoo; E W Johnson; J W Thomas; P M Kuehl; T L Jones; C G Dokken; J W Touchman; C J Gallione; S Q Lee-Lin; B Kosofsky; J H Kurth; D N Louis; G Mettler; L Morrison; A Gil-Nagel; S S Rich; J M Zabramski; M S Boguski; E D Green; D A Marchuk
Journal:  Hum Mol Genet       Date:  1999-11       Impact factor: 6.150

7.  Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1).

Authors:  Hildegard Kehrer-Sawatzki; Monika Wilda; Veit M Braun; Hans-Peter Richter; Horst Hameister
Journal:  Acta Neuropathol       Date:  2002-06-26       Impact factor: 17.088

8.  Krev1 interaction trapped-1/cerebral cavernous malformation-1 protein expression during early angiogenesis.

Authors:  Ozlem Guzeloglu-Kayisli; Umit A Kayisli; Nduka M Amankulor; Jennifer R Voorhees; Ozgun Gokce; Michael L DiLuna; Maxwell S H Laurans; Guven Luleci; Murat Gunel
Journal:  J Neurosurg       Date:  2004-05       Impact factor: 5.115

9.  Mutations within the MGC4607 gene cause cerebral cavernous malformations.

Authors:  C Denier; S Goutagny; P Labauge; V Krivosic; M Arnoult; A Cousin; A L Benabid; J Comoy; P Frerebeau; B Gilbert; J P Houtteville; M Jan; F Lapierre; H Loiseau; P Menei; P Mercier; J J Moreau; A Nivelon-Chevallier; F Parker; A M Redondo; J M Scarabin; M Tremoulet; M Zerah; J Maciazek; E Tournier-Lasserve
Journal:  Am J Hum Genet       Date:  2004-01-22       Impact factor: 11.025

10.  KRIT1/cerebral cavernous malformation 1 protein localizes to vascular endothelium, astrocytes, and pyramidal cells of the adult human cerebral cortex.

Authors:  Ozlem Guzeloglu-Kayisli; Nduka M Amankulor; Jennifer Voorhees; Guven Luleci; Richard P Lifton; Murat Gunel
Journal:  Neurosurgery       Date:  2004-04       Impact factor: 4.654

View more
  30 in total

Review 1.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

2.  PDCD10/CCM3 acts downstream of {gamma}-protocadherins to regulate neuronal survival.

Authors:  Chengyi Lin; Shuxia Meng; Tina Zhu; Xiaozhong Wang
Journal:  J Biol Chem       Date:  2010-11-01       Impact factor: 5.157

Review 3.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

Review 4.  Cerebrovascular disorders associated with genetic lesions.

Authors:  Philipp Karschnia; Sayoko Nishimura; Angeliki Louvi
Journal:  Cell Mol Life Sci       Date:  2018-10-16       Impact factor: 9.261

Review 5.  Vascular anomalies: from genetics toward models for therapeutic trials.

Authors:  Melanie Uebelhoer; Laurence M Boon; Miikka Vikkula
Journal:  Cold Spring Harb Perspect Med       Date:  2012-08-01       Impact factor: 6.915

6.  Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models.

Authors:  Robert Shenkar; Palamadai N Venkatasubramanian; Alice M Wyrwicz; Jin-cheng Zhao; Changbin Shi; Amy Akers; Douglas A Marchuk; Issam A Awad
Journal:  Neurosurgery       Date:  2008-10       Impact factor: 4.654

Review 7.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

8.  Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.

Authors:  Rebecca A Stockton; Robert Shenkar; Issam A Awad; Mark H Ginsberg
Journal:  J Exp Med       Date:  2010-03-22       Impact factor: 14.307

9.  The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases.

Authors:  Kevin J Whitehead; Aubrey C Chan; Sutip Navankasattusas; Wonshill Koh; Nyall R London; Jing Ling; Anne H Mayo; Stavros G Drakos; Christopher A Jones; Weiquan Zhu; Douglas A Marchuk; George E Davis; Dean Y Li
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

10.  Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway.

Authors:  Benjamin Kleaveland; Xiangjian Zheng; Jian J Liu; Yannick Blum; Jennifer J Tung; Zhiying Zou; Shawn M Sweeney; Mei Chen; Lili Guo; Min-min Lu; Diane Zhou; Jan Kitajewski; Markus Affolter; Mark H Ginsberg; Mark L Kahn
Journal:  Nat Med       Date:  2009-01-18       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.